1. Aabo K, Adams M, Adnitt P, Alberts DS, Barley V, Bell DR, Bianchi U, Bolis G, Brady MF, Brodovsky HS, Bruckner H, Buyse M, Canetta R, Chylak V, Cohen CJ, Colombo N, Conte PF, Crowther D, Edmonson JH, Gennatas C, Gilbey E, Gore M, Guthrie D, Yeap BY (1998) Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group. Br J Cancer 78: 1479–1487
2. Advanced Ovarian Cancer Trialists' Group (2000) Chemotherapy for advanced ovarian cancer. Cochrane Database Syst Rev 2: CD001418
3. A'Hern RP, Gore ME (1995) Impact of doxorubicin on survival in advanced ovarian cancer. J Clin Oncol 13: 726–732
4. American Cancer Society (2003) What are the key statistics about ovarian cancer? Available from: URL:
http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_ovarian_cancer_33.asp?sitearea=
[accessed 6 July 2003]
5. Beers MH, Berkow R (eds) 1999) Ovarian cancer. In The Merck Manual of Diagnosis and Therapy, 17th edn, pp 1962–1964. Whitehouse Station, NJ: Merck Research Laboratories